DDDHIGH SIGNALFINANCIAL10-K

DDD shows substantial deterioration in operating cash flow alongside meaningful operating loss reduction, indicating potential financial distress despite restructuring progress.

The company appears to be executing a significant restructuring effort, evidenced by reduced R&D and SG&A expenses leading to improved operating losses. However, the substantial worsening of operating cash flow raises concerns about the company's ability to generate cash from operations. The reduction in total liabilities and improvement in stockholders' equity suggests balance sheet strengthening efforts, but liquidity concerns persist given the declining cash position and negative cash generation.

Comparing 2026-03-09 vs 2025-03-27View on EDGAR →
FINANCIAL ANALYSIS

DDD demonstrated mixed financial performance with operating losses improving meaningfully due to substantial cost reductions in R&D and SG&A expenses, though gross profit declined modestly. However, operating cash flow deteriorated substantially while cash reserves fell significantly, creating potential liquidity concerns. The balance sheet showed improvement through reduced total liabilities and higher stockholders' equity, suggesting ongoing restructuring efforts, but the company's ability to generate positive cash flow from operations remains challenged.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
-95.7%
-$44.9M→-$87.8M

Operating cash flow fell 95.7% — earnings quality concerns; investigate working capital changes and non-cash items.

Operating Income
P&L
+65.4%
-$277.4M→-$96.1M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Interest Expense
P&L
-46.7%
$4.4M→$2.3M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Cash & Equivalents
Balance Sheet
-44.2%
$171.3M→$95.6M

Cash declined 44.2% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Capital Expenditure
Cash Flow
-38.3%
$16.1M→$9.9M

Capex reduced 38.3% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Stockholders Equity
Balance Sheet
+36.4%
$176.2M→$240.4M

Equity base grew 36.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Liabilities
Balance Sheet
-35.2%
$430.7M→$279.2M

Liabilities reduced 35.2% — deleveraging improves balance sheet strength and financial flexibility.

R&D Expense
P&L
-24.8%
$86.5M→$65.0M

R&D spending cut 24.8% — could signal cost discipline or concerning reduction in innovation investment.

SG&A Expense
P&L
-23.2%
$210.1M→$161.3M

SG&A reduced 23.2% — improved cost efficiency or headcount reduction improving operating margins.

Gross Profit
P&L
-20.2%
$164.2M→$131.0M

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

LANGUAGE CHANGES
NEW — 2026-03-09
PRIOR — 2025-03-27
ADDED
See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
For purposes of this computation, it has been assumed that the shares beneficially held by directors and executive officers of the registrant were "held by affiliates." This assumption is not to be deemed an admission by these persons that they are affiliates of the registrant.
Form 10-K Summary 48 3 This Annual Report on Form 10-K ("Form 10-K") contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties.
Many of the forward-looking statements are located in Part II, Item 7 of this Form 10-K under the heading "Management s Discussion and Analysis of Financial Condition and Results of Operations." Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from historical results or from any future results expressed or implied by such forward-looking statements.
In many cases, you can identify forward-looking statements by terms such as "believes," "belief," "expects," "may," "will," "estimates," "intends," "anticipates," or "plans" or the negative of these terms or other comparable terminology.
+7 more — sign up free →
REMOVED
See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
For purposes of this computation, it has been assumed that the shares beneficially held by directors and executive officers of the registrant were held by affiliates.
This assumption is not to be deemed an admission by these persons that they are affiliates of the registrant.
Form 10-K Summary 61 3 This Annual Report on Form 10-K ( Form 10-K ) contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties.
Many of the forward-looking statements are located in Part II, Item 7 of this Form 10-K under the heading Management s Discussion and Analysis of Financial Condition and Results of Operations.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →